Skip to content

Opening book details…

About this Medicine article

TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies by Burris, Howard A.; Kurkjian, C. D.; Hart, L.; Pant, S.; Murphy, P. B.; Jones, S. F.; Neuwirth, R.; Patel, C. G.; Zohren, F.; Infante, J. R. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Burris, Howard A.; Kurkjian, C. D.; Hart, L.; Pant, S.; Murphy, P. B.; Jones, S. F.; Neuwirth, R.; Patel, C. G.; Zohren, F.; Infante, J. R.
Publisher
Springer; Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 0344-5704)
Published
2017
Language
EN
Field
Medicine (Health Sciences)

More by Burris, Howard A.; Kurkjian, C. D.; Hart, L.; Pant, S.; Murphy, P. B.; Jones, S. F.; Neuwirth, R.; Patel, C. G.; Zohren, F.; Infante, J. R.

Browse all works by Burris, Howard A.; Kurkjian, C. D.; Hart, L.; Pant, S.; Murphy, P. B.; Jones, S. F.; Neuwirth, R.; Patel, C. G.; Zohren, F.; Infante, J. R.